Efficacy and Safety of a Magnesium Sulfate-Rich Natural Mineral Water for Patients With Functional Constipation

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 8, 2014, Pages 1280-1287

  Dupont, Christophe ^a   Campagne, Alain ^b   Constant, Florence ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b General Practitioner   (France)

^c Nestlé Waters M T   (France)

Author keywords

Bowel Movement; Clinical Trial; Mineral Water; Treatment

Indexed keywords

'HEPAR'; MAGNESIUM SULFATE; MAGNESIUM SULFATE RICH NATURAL MINERAL WATER; MINERAL WATER; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; BRISTOL SCALE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONSTIPATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FECES; FEMALE; FOLLOW UP; FRANCE; FUNCTIONAL CONSTIPATION; GASTROINTESTINAL TRANSIT; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; CLINICAL EFFECTIVENESS; FLUID INTAKE; MALE; QUALITY OF LIFE; SAFETY; ADOLESCENT; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CONSTIPATION; FEMALE; FRANCE; HUMANS; MAGNESIUM SULFATE; MIDDLE AGED; MINERAL WATERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904385111     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.12.005     Document Type: Article

References (24)

1. Suares N.C., Ford A.C. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review andmeta-analysis. Am J Gastroenterol 2011, 106:1582-1591. quiz1,92.
2. Wald A., Scarpignato C., Kamm M.A., et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007, 26:227-236.
3. Rantis P.C., Vernava A.M., Daniel G.L., et al. Chronic constipation-is the work-up worth the cost?. Dis Colon Rectum 1997, 40:280-286.
4. Sonnenberg A., Koch T.R. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci 1989, 34:606-611.
5. Piche T., Dapoigny M., Bouteloup C., et al. [Recommendations for the clinical management and treatment of chronic constipation in adults]. Gastroenterol Clin Biol 2007, 31:125-135.
6. Suares N.C., Ford A.C. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 2011, 33:895-901.
7. Markland A.D., Palsson O., Goode P.S., et al. Association of low dietary intake of fiber and liquids with constipation: evidence from the national health and nutrition examination survey. Am J Gastroenterol 2013, 108:796-803.
8. Esteban E., Rubin C.H., McGeehin M.A., et al. Evaluation of Infant diarrhea associated with elevated levels of sulfate in drinking water: a case-control investigation in South Dakota. Int J Occup Environ Health 1997, 3:171-176.
9. Gomes P.B., Duarte M.A., Melo Mdo C. Comparison of the effectiveness of polyethylene glycol 4000 without electrolytes and magnesium hydroxide in the treatment of chronic functional constipation in children. JPediatr (Rio J) 2011, 87:24-28.
10. Heizer W.D., Sandler R.S., Seal E., et al. Intestinal effects of sulfate in drinking water on normal human subjects. Dig Dis Sci 1997, 42:1055-1061.
11. Ikarashi N., Ushiki T., Mochizuki T., et al. Effects of magnesium sulphate administration on aquaporin 3 in rat gastrointestinal tract. Biol Pharm Bull 2011, 34:238-242.
12. Izzo A.A., Gaginella T.S., Mascolo N., et al. Nitric oxide as a mediator of the laxative action of magnesium sulphate. Br J Pharmacol 1994, 113:228-232.
13. Kinnunen O., Salokannel J. Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk-laxative. Ann Clin Res 1987, 19:321-323.
14. Murakami K., Sasaki S., Okubo H., et al. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur J Clin Nutr 2007, 61:616-622.
15. Vu M.K., Nouwens M.A., Biemond I., et al. The osmotic laxative magnesium sulphate activates the ileal brake. Aliment Pharmacol Ther 2000, 14:587-595.
16. WHO. Sulfate in drinking water. Background document fordevelopment of WHO Guidelines for Drinking-water Quality. WHO/SDE/WSH/0304/1142004. Available at: Accessed February 21, 2014. http://www.who.int/water_sanitation_health/dwq/chemicals/sulfate.pdf.
17. Académie de Médecine. Rapport sur la source salée de Vittel (Vosges). Bulletin de l'Académie de Médecine 1875;4:263-264.
18. Académie de Médecine. Sur des demandes de changement de nom de sources Hydrominérales autorisées, au nom de la Commission des Eaux minérales. Bulletin de l'Académie de Médecine 1919;82:499.
19. Constant F., Morali A., Arnaud M., et al. Treatment of idiopathic constipation in infants: comparative and randomized study of two mineral waters (60 cases). JPediatr Gastroenterol Nutr 1999, 28:551.
20. Rome III criteria. 2006. Available at: Accessed September 27,2013. http://www.romecriteria.org/.
21. Lewis S.J., Heaton K.W. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997, 32:920-924.
22. Marquis P., De La Loge C., Dubois D., et al. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol 2005, 40:540-551.
23. Nam J.M. Asimple approximation for calculating sample sizes for detecting linear trend in proportions. Biometrics 1987, 43:701-705.
24. International Conference on Harmonisation (ICH). Guidance forindustry: E9 Statistical principles for clinical trials. 1998. Available at: AccessedFebruary 21, 2014. http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/statistical-principles-for-clinical-trials.html.